264 related articles for article (PubMed ID: 37478846)
21. To be (in a transcriptional complex) or not to be (promoting UBR5 ubiquitylation): That is an answer to how degradation controls gene expression.
Hehl LA; Schulman BA
Mol Cell; 2023 Aug; 83(15):2616-2618. PubMed ID: 37541216
[TBL] [Abstract][Full Text] [Related]
22.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
23. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
24. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
25. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta.
Johansson L; Thomsen JS; Damdimopoulos AE; Spyrou G; Gustafsson JA; Treuter E
J Biol Chem; 1999 Jan; 274(1):345-53. PubMed ID: 9867849
[TBL] [Abstract][Full Text] [Related]
26. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced
Wu B; Song M; Dong Q; Xiang G; Li J; Ma X; Wei F
Theranostics; 2022; 12(11):5086-5102. PubMed ID: 35836797
[No Abstract] [Full Text] [Related]
27. Transcriptional controls by nuclear fat-soluble vitamin receptors through chromatin reorganization.
Kato S; Fujiki R
Biosci Biotechnol Biochem; 2011; 75(3):410-3. PubMed ID: 21389633
[TBL] [Abstract][Full Text] [Related]
28. BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin.
Sanchez A; De Vivo A; Uprety N; Kim J; Stevens SM; Kee Y
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11243-11248. PubMed ID: 27647897
[TBL] [Abstract][Full Text] [Related]
29. The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia.
Amhaz S; Boëda B; Chouchène M; Colasse S; Dingli F; Loew D; Henri J; Prunier C; Levy L
BMC Biol; 2023 Apr; 21(1):73. PubMed ID: 37024974
[TBL] [Abstract][Full Text] [Related]
30. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
Osburn DL; Shao G; Seidel HM; Schulman IG
Mol Cell Biol; 2001 Aug; 21(15):4909-18. PubMed ID: 11438648
[TBL] [Abstract][Full Text] [Related]
31. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract][Full Text] [Related]
32. PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1).
Zhou D; Quach KM; Yang C; Lee SY; Pohajdak B; Chen S
Mol Endocrinol; 2000 Jul; 14(7):986-98. PubMed ID: 10894149
[TBL] [Abstract][Full Text] [Related]
33. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
34. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
Redinger RN
Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
[TBL] [Abstract][Full Text] [Related]
35. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
Bethard JR; Zheng H; Roberts L; Eblen ST
J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
[TBL] [Abstract][Full Text] [Related]
36. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.
Lee SK; Anzick SL; Choi JE; Bubendorf L; Guan XY; Jung YK; Kallioniemi OP; Kononen J; Trent JM; Azorsa D; Jhun BH; Cheong JH; Lee YC; Meltzer PS; Lee JW
J Biol Chem; 1999 Nov; 274(48):34283-93. PubMed ID: 10567404
[TBL] [Abstract][Full Text] [Related]
37. Endometriosis and nuclear receptors.
Yilmaz BD; Bulun SE
Hum Reprod Update; 2019 Jul; 25(4):473-485. PubMed ID: 30809650
[TBL] [Abstract][Full Text] [Related]
38. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA.
Mouchon A; Delmotte MH; Formstecher P; Lefebvre P
Mol Cell Biol; 1999 Apr; 19(4):3073-85. PubMed ID: 10082574
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2.
Leers J; Treuter E; Gustafsson JA
Mol Cell Biol; 1998 Oct; 18(10):6001-13. PubMed ID: 9742117
[TBL] [Abstract][Full Text] [Related]
40. Human nuclear receptor heterodimers: opportunities for detecting targets of transcriptional regulation using yeast.
Butt TR; Walfish PG
Gene Expr; 1996; 5(4-5):255-68. PubMed ID: 8723391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
